evaluate the pharmaceuticals company byetta on glp-1 medications comparison future of drugs in healthcare: Vital's role in enhancing metabolic treatment programs GLP-1 Agonists Explained: Definition, How

Cited 6/16/14

They dont mean a drug should never be used

Health Drug Benefits 10 (4), 178188 (2017)

Certain GLP-1 formulations have demonstrated cardiovascular benefits in clinical trials, leading to specific FDA approvals: Victoza, Ozempic, and Trulicity are approved for reducing major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease, while Wegovy is approved for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight

The relationship between semaglutide and blood clots is far more complicated than a single relative risk number suggests